Forgot your password?

Forgot your username?

Admedus Corp.

8400 Normandale Lake Blvd Suite 920
Minneapolis, MN 55437 USA
Click for website
Research Sector Tissue Impants
Summary Description A new generation of tissue bio-implants that more easily integrate into recipient tissue, show less capacity for rejection and have the potential to replace many of the products that surgeons currently use.

Click here for Financial Data KeywordsRegenerative Tissue, Bio-Implants, Rejection, Surgery, Heart


Admedus Corp. is the American arm of Australian ASX-listed Admedus Ltd a diversified healthcare company focused on developing and commericalizing technologies with global potential. Working with ......view more

Products / Services

CardioCel? - A solution for life. CardioCel? is currently undergoing regulatory approval in the US but is now available for sale in Europe. CardioCel? is a new type of cardiovascular scaffold that......view more

Technology / Differentiation

Our patented ADAPT? tissue engineering process has enabled our scientific team to create a biological scaffold that more readily promotes native tissue in-growth. Tissue bio-implants developed usin...view more

Market / Customers

Cardiovascular Surgery......view more


    Deprecated: mysql_connect(): The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /home/onemedpl/public_html/include/counter.php on line 10